Literature DB >> 21764617

Moving toward personalized cell-based interventions for adrenal cortical disorders: part 2--Human diseases and tissue engineering.

Jaime K Mazilu1, Edward R B McCabe.   

Abstract

Transdifferentiation of an individual's own cells into functional differentiated cells to replace an organ's lost function would be a personalized approach to therapeutics. In this two part series, we will describe the progress toward establishing functional transdifferentiated adrenal cortical cells. In this article (Part 2), we describe the disorders of the adrenal cortex, therefore establishing why there is the need for personalized cell-based therapy for individuals with these disorders. We then present our pilot studies of cell transdifferentiation toward an adrenal cortical fate using genes described in the first article of this pair (Part 1).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764617     DOI: 10.1016/j.ymgme.2011.06.011

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  2 in total

Review 1.  New directions for the treatment of adrenal insufficiency.

Authors:  Gerard Ruiz-Babot; Irene Hadjidemetriou; Peter James King; Leonardo Guasti
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-06       Impact factor: 5.555

2.  Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells.

Authors:  Gerard Ruiz-Babot; Mariya Balyura; Irene Hadjidemetriou; Sharon J Ajodha; David R Taylor; Lea Ghataore; Norman F Taylor; Undine Schubert; Christian G Ziegler; Helen L Storr; Maralyn R Druce; Evelien F Gevers; William M Drake; Umasuthan Srirangalingam; Gerard S Conway; Peter J King; Louise A Metherell; Stefan R Bornstein; Leonardo Guasti
Journal:  Cell Rep       Date:  2018-01-30       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.